SC 13D

Company

Aurinia Pharmaceuticals Inc.

Filed

April 8, 2019

Accession Number

0001104659-19-020260

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →